Global Hematological Malignancies Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 93

Report ID: 1787

Hematologic malignancies are forms of cancer that begin in the cells of blood-forming tissue, such as the bone marrow, or in the cells of the immune system.
In 2018, the global Hematological Malignancies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Hematological Malignancies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hematological Malignancies development in United States, Europe and China.

The key players covered in this study
AbbVie
Bristol-Myers Squibb
Celgene
Roche
GlaxoSmithKline
Johnson & Johnson
Novartis
Pfizer
Teva Pharmaceutical

Market segment by Type, the product can be split into
Leukemia
Lymphoma
Myeloma

Market segment by Application, split into
Hospital Pharmacies
Medical Stores
E-commerce Platform

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Hematological Malignancies status, future forecast, growth opportunity, key market and key players.
To present the Hematological Malignancies development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Hematological Malignancies are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Hematological Malignancies Market Size Growth Rate by Type (2014-2025)
1.4.2 Leukemia
1.4.3 Lymphoma
1.4.4 Myeloma
1.5 Market by Application
1.5.1 Global Hematological Malignancies Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Medical Stores
1.5.4 E-commerce Platform
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Hematological Malignancies Market Size
2.2 Hematological Malignancies Growth Trends by Regions
2.2.1 Hematological Malignancies Market Size by Regions (2014-2025)
2.2.2 Hematological Malignancies Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Hematological Malignancies Market Size by Manufacturers
3.1.1 Global Hematological Malignancies Revenue by Manufacturers (2014-2019)
3.1.2 Global Hematological Malignancies Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Hematological Malignancies Market Concentration Ratio (CR5 and HHI)
3.2 Hematological Malignancies Key Players Head office and Area Served
3.3 Key Players Hematological Malignancies Product/Solution/Service
3.4 Date of Enter into Hematological Malignancies Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Hematological Malignancies Market Size by Type (2014-2019)
4.2 Global Hematological Malignancies Market Size by Application (2014-2019)

5 United States
5.1 United States Hematological Malignancies Market Size (2014-2019)
5.2 Hematological Malignancies Key Players in United States
5.3 United States Hematological Malignancies Market Size by Type
5.4 United States Hematological Malignancies Market Size by Application

6 Europe
6.1 Europe Hematological Malignancies Market Size (2014-2019)
6.2 Hematological Malignancies Key Players in Europe
6.3 Europe Hematological Malignancies Market Size by Type
6.4 Europe Hematological Malignancies Market Size by Application

7 China
7.1 China Hematological Malignancies Market Size (2014-2019)
7.2 Hematological Malignancies Key Players in China
7.3 China Hematological Malignancies Market Size by Type
7.4 China Hematological Malignancies Market Size by Application

8 Japan
8.1 Japan Hematological Malignancies Market Size (2014-2019)
8.2 Hematological Malignancies Key Players in Japan
8.3 Japan Hematological Malignancies Market Size by Type
8.4 Japan Hematological Malignancies Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Hematological Malignancies Market Size (2014-2019)
9.2 Hematological Malignancies Key Players in Southeast Asia
9.3 Southeast Asia Hematological Malignancies Market Size by Type
9.4 Southeast Asia Hematological Malignancies Market Size by Application

10 India
10.1 India Hematological Malignancies Market Size (2014-2019)
10.2 Hematological Malignancies Key Players in India
10.3 India Hematological Malignancies Market Size by Type
10.4 India Hematological Malignancies Market Size by Application

11 Central & South America
11.1 Central & South America Hematological Malignancies Market Size (2014-2019)
11.2 Hematological Malignancies Key Players in Central & South America
11.3 Central & South America Hematological Malignancies Market Size by Type
11.4 Central & South America Hematological Malignancies Market Size by Application

12 International Players Profiles
12.1 AbbVie
12.1.1 AbbVie Company Details
12.1.2 Company Description and Business Overview
12.1.3 Hematological Malignancies Introduction
12.1.4 AbbVie Revenue in Hematological Malignancies Business (2014-2019)
12.1.5 AbbVie Recent Development
12.2 Bristol-Myers Squibb
12.2.1 Bristol-Myers Squibb Company Details
12.2.2 Company Description and Business Overview
12.2.3 Hematological Malignancies Introduction
12.2.4 Bristol-Myers Squibb Revenue in Hematological Malignancies Business (2014-2019)
12.2.5 Bristol-Myers Squibb Recent Development
12.3 Celgene
12.3.1 Celgene Company Details
12.3.2 Company Description and Business Overview
12.3.3 Hematological Malignancies Introduction
12.3.4 Celgene Revenue in Hematological Malignancies Business (2014-2019)
12.3.5 Celgene Recent Development
12.4 Roche
12.4.1 Roche Company Details
12.4.2 Company Description and Business Overview
12.4.3 Hematological Malignancies Introduction
12.4.4 Roche Revenue in Hematological Malignancies Business (2014-2019)
12.4.5 Roche Recent Development
12.5 GlaxoSmithKline
12.5.1 GlaxoSmithKline Company Details
12.5.2 Company Description and Business Overview
12.5.3 Hematological Malignancies Introduction
12.5.4 GlaxoSmithKline Revenue in Hematological Malignancies Business (2014-2019)
12.5.5 GlaxoSmithKline Recent Development
12.6 Johnson & Johnson
12.6.1 Johnson & Johnson Company Details
12.6.2 Company Description and Business Overview
12.6.3 Hematological Malignancies Introduction
12.6.4 Johnson & Johnson Revenue in Hematological Malignancies Business (2014-2019)
12.6.5 Johnson & Johnson Recent Development
12.7 Novartis
12.7.1 Novartis Company Details
12.7.2 Company Description and Business Overview
12.7.3 Hematological Malignancies Introduction
12.7.4 Novartis Revenue in Hematological Malignancies Business (2014-2019)
12.7.5 Novartis Recent Development
12.8 Pfizer
12.8.1 Pfizer Company Details
12.8.2 Company Description and Business Overview
12.8.3 Hematological Malignancies Introduction
12.8.4 Pfizer Revenue in Hematological Malignancies Business (2014-2019)
12.8.5 Pfizer Recent Development
12.9 Teva Pharmaceutical
12.9.1 Teva Pharmaceutical Company Details
12.9.2 Company Description and Business Overview
12.9.3 Hematological Malignancies Introduction
12.9.4 Teva Pharmaceutical Revenue in Hematological Malignancies Business (2014-2019)
12.9.5 Teva Pharmaceutical Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details